CA2485201C - Camptothecins with a modified lactone ring - Google Patents

Camptothecins with a modified lactone ring Download PDF

Info

Publication number
CA2485201C
CA2485201C CA2485201A CA2485201A CA2485201C CA 2485201 C CA2485201 C CA 2485201C CA 2485201 A CA2485201 A CA 2485201A CA 2485201 A CA2485201 A CA 2485201A CA 2485201 C CA2485201 C CA 2485201C
Authority
CA
Canada
Prior art keywords
homocamptothecin
group
branched
straight
alkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CA2485201A
Other languages
English (en)
French (fr)
Other versions
CA2485201A1 (en
Inventor
Mauro Marzi
Elena Marastoni
Sergio Penco
Claudio Pisano
Maria Ornella Tinti
Loredana Vesci
Franco Zunino
Domenico Vergani
Walter Cabri
Marco Alpegiani
Tamara Danelli
Martin Gomez Patricio
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Istituto Nazionale per lo Studio e la Cura die Tumori
Sigma Tau Industrie Farmaceutiche Riunite SpA
Original Assignee
Istituto Nazionale per lo Studio e la Cura die Tumori
Sigma Tau Industrie Farmaceutiche Riunite SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Istituto Nazionale per lo Studio e la Cura die Tumori, Sigma Tau Industrie Farmaceutiche Riunite SpA filed Critical Istituto Nazionale per lo Studio e la Cura die Tumori
Priority to CA2706635A priority Critical patent/CA2706635A1/en
Publication of CA2485201A1 publication Critical patent/CA2485201A1/en
Application granted granted Critical
Publication of CA2485201C publication Critical patent/CA2485201C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/22—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains four or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Epoxy Compounds (AREA)
CA2485201A 2002-05-31 2003-05-28 Camptothecins with a modified lactone ring Expired - Fee Related CA2485201C (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CA2706635A CA2706635A1 (en) 2002-05-31 2003-05-28 Camptothecins with a modified lactone ring

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
ITRM2002A000305 2002-05-31
IT2002RM000305A ITRM20020305A1 (it) 2002-05-31 2002-05-31 Camptotecine con anello lattonico modificato.
PCT/IT2003/000328 WO2003101995A2 (en) 2002-05-31 2003-05-28 Camptothecins with a modified lactone ring

Related Child Applications (1)

Application Number Title Priority Date Filing Date
CA2706635A Division CA2706635A1 (en) 2002-05-31 2003-05-28 Camptothecins with a modified lactone ring

Publications (2)

Publication Number Publication Date
CA2485201A1 CA2485201A1 (en) 2003-12-11
CA2485201C true CA2485201C (en) 2010-11-02

Family

ID=11456338

Family Applications (2)

Application Number Title Priority Date Filing Date
CA2485201A Expired - Fee Related CA2485201C (en) 2002-05-31 2003-05-28 Camptothecins with a modified lactone ring
CA2706635A Abandoned CA2706635A1 (en) 2002-05-31 2003-05-28 Camptothecins with a modified lactone ring

Family Applications After (1)

Application Number Title Priority Date Filing Date
CA2706635A Abandoned CA2706635A1 (en) 2002-05-31 2003-05-28 Camptothecins with a modified lactone ring

Country Status (22)

Country Link
US (1) US7273873B2 (https=)
EP (2) EP1719775B1 (https=)
JP (1) JP4693410B2 (https=)
KR (1) KR101042042B1 (https=)
CN (1) CN1656100A (https=)
AR (1) AR040139A1 (https=)
AT (2) ATE403659T1 (https=)
AU (2) AU2003241160B2 (https=)
BR (2) BR0311333A (https=)
CA (2) CA2485201C (https=)
CY (2) CY1107311T1 (https=)
DE (2) DE60322754D1 (https=)
DK (2) DK1719775T3 (https=)
ES (2) ES2273002T7 (https=)
IT (1) ITRM20020305A1 (https=)
MX (1) MXPA04011682A (https=)
PE (1) PE20050120A1 (https=)
PL (1) PL374346A1 (https=)
PT (2) PT1719775E (https=)
SI (2) SI1511752T1 (https=)
TW (1) TWI325866B (https=)
WO (1) WO2003101995A2 (https=)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2852606A1 (fr) * 2003-03-18 2004-09-24 Inst Nat Sante Rech Med Moyens pour inhiber simultanement l'expression de plusieurs genes impliques dans une pathologie
ITRM20030344A1 (it) * 2003-07-14 2005-01-15 Ist Naz Stud Cura Dei Tumori 7-n-poliamminoalchil(ossi)imminometilcamptotecine recanti gruppi protettivi.
PT2170900E (pt) 2007-08-01 2013-01-24 Sigma Tau Ind Farmaceuti Forma cristalina ii de 7-(dimetoximetil)-camptotecina, sua utilização como intermediário e produtos obtidos a partir dela
CN102746314B (zh) * 2011-04-18 2016-07-06 华东师范大学 含有稳定7元内酯环的喜树碱类化合物、制备方法和用途
CN104530066A (zh) * 2015-01-06 2015-04-22 华东师范大学 一类新型高喜树碱衍生物、制备方法和用途
CA3099155A1 (en) 2018-05-14 2019-11-21 Nuvation Bio Inc. Anti-cancer nuclear hormone receptor-targeting compounds
CA3138197A1 (en) 2019-05-14 2020-11-19 Nuvation Bio Inc. Anti-cancer nuclear hormone receptor-targeting compounds
EP4058464A1 (en) 2019-11-13 2022-09-21 Nuvation Bio Inc. Anti-cancer nuclear hormone receptor-targeting compounds
MX2023011241A (es) 2021-03-23 2023-10-03 Nuvation Bio Inc Compuestos dirigidos a receptores de hormonas nucleares contra el cancer.
JP2024516024A (ja) 2021-05-03 2024-04-11 ニューベイション・バイオ・インコーポレイテッド 抗がん核内ホルモン受容体標的化化合物
WO2024073626A2 (en) * 2022-09-28 2024-04-04 Nuvation Bio Inc. Anti-cancer nuclear hormone receptor-targeting compounds

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS57116076A (en) * 1981-01-09 1982-07-19 Yakult Honsha Co Ltd Novel camptothecin derivative and its preparation
US4399276A (en) * 1981-01-09 1983-08-16 Kabushiki Kaisha Yakult Honsha 7-Substituted camptothecin derivatives
FR2532591A1 (fr) 1982-09-02 1984-03-09 Hutchinson Nouveau dispositif de securite pour pneumatiques de vehicules ou autres engins
DE69623961T2 (de) * 1995-06-21 2003-05-08 Societe De Conseils De Recherches Et D'applications Scientifiques (S.C.R.A.S.), Paris Camptothecinanaloge, verfahren zur ihrer herstellung, ihre verwendungals arzneimittel und diese enthaltende pharmazeutische zusammenfassungen
EP1044977B1 (en) 1999-03-09 2002-05-02 Sigma-Tau Industrie Farmaceutiche Riunite S.p.A. Camptothecin derivatives having antitumor activity

Also Published As

Publication number Publication date
ES2312090T3 (es) 2009-02-16
WO2003101995A3 (en) 2004-02-19
EP1719775A1 (en) 2006-11-08
KR20050036909A (ko) 2005-04-20
PL374346A1 (en) 2005-10-17
WO2003101995A8 (en) 2004-12-23
DE60322754D1 (de) 2008-09-18
DE60308368T3 (de) 2010-09-16
EP1511752B1 (en) 2006-09-13
EP1511752B3 (en) 2010-03-10
CN1656100A (zh) 2005-08-17
DE60308368D1 (de) 2006-10-26
BR0311329A (pt) 2005-02-22
CY1108793T1 (el) 2014-04-09
DK1511752T5 (da) 2010-06-14
AU2003241160A1 (en) 2003-12-19
JP4693410B2 (ja) 2011-06-01
AU2009236044A1 (en) 2009-12-03
EP1511752A2 (en) 2005-03-09
AU2009236044A8 (en) 2011-07-21
EP1511752B8 (en) 2007-04-18
US20050154003A1 (en) 2005-07-14
AU2003241160B2 (en) 2009-08-20
EP1719775B1 (en) 2008-08-06
AU2009236044B8 (en) 2011-07-21
CA2485201A1 (en) 2003-12-11
WO2003101995A2 (en) 2003-12-11
JP2005531602A (ja) 2005-10-20
BR0311333A (pt) 2005-03-15
AU2009236044B2 (en) 2011-03-24
TWI325866B (en) 2010-06-11
US7273873B2 (en) 2007-09-25
ITRM20020305A1 (it) 2003-12-01
PE20050120A1 (es) 2005-03-04
AR040139A1 (es) 2005-03-16
CY1107311T1 (el) 2012-11-21
ES2273002T3 (es) 2007-05-01
MXPA04011682A (es) 2005-03-31
ES2273002T7 (es) 2011-08-01
ITRM20020305A0 (it) 2002-05-31
TW200404806A (en) 2004-04-01
ATE339422T1 (de) 2006-10-15
ATE403659T1 (de) 2008-08-15
PT1719775E (pt) 2008-09-30
DK1511752T3 (da) 2007-01-29
PT1511752E (pt) 2007-01-31
CA2706635A1 (en) 2003-12-11
DE60308368T2 (de) 2007-09-06
DK1719775T3 (da) 2008-11-17
KR101042042B1 (ko) 2011-06-16
SI1719775T1 (sl) 2009-04-30
SI1511752T1 (sl) 2007-02-28

Similar Documents

Publication Publication Date Title
AU2009236044B8 (en) Camptothecins with a modified lactone ring
ES2561356T3 (es) Derivados de camptotecina con actividad antitumoral
AU2007278509B2 (en) Camptothecin derivatives with antitumor activity
CA2659050C (en) Camptothecin derivatives with antitumor activity
HK1135693B (en) Camptothecin derivatives with antitumor activity

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed

Effective date: 20130528